DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02696 HENLIUS

Trading Add to Porfolio
Index Constituent : None
Major Shareholders [02196] Shanghai Fosun Pharmaceutical (Group) Company Limited (60.68%)
Scott Shi-Kau Liu & Associates (8.49%)		 Sector Health Care & Biotechnology
Web Site http://www.henlius.com Tel (86 21) 3339-5800
Email IR@Henlius.com Fax (86 21) 3461-1802
Related Equities N/A
Principal Activities Principal activities are biopharmaceutical research and development (“biopharmaceutical R&D”), biopharmaceutical service, and biopharmaceutical production and sales.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top